WuXi Chemistry
Pharmaceutical ManufacturingShanghai, China201-500 Employees
WuXi Chemistry, a division of WuXi AppTec, provides contract services for drug development from discovery through commercialization. It offers an integrated CRDMO model that combines CRO, CDMO, and CMO functions under one roof, enabling seamless progress from early research to commercial supply. The company serves a broad client base, including large pharmaceutical companies and virtual biotech firms, with capabilities across all synthetic molecular modalities and scales. Based in Shanghai, China, it operates globally and serves more than two thousand clients. As context within its ecosystem, WuXi STA announced the opening of a Sterile Lipid Nanoparticle Formulation Facility in September 2022 to expand its CRDMO capabilities. This development illustrates the platform's ongoing expansion to support end-to-end drug development and manufacturing across modalities.
1-888-653-2347 
support@leadiq.com 
